Enter your e-mail address below
to reset your password.
Please activate your registration
by clicking the link in the activation email
or click submit to resend the activation email.
Please check your spam folder too...
Check your mailbox to activate your registration.
Please check your spam folder too.
Johnson & Johnson's Prezista, a treatment for people infected with the AIDS virus, won conditional approval to be marketed in the European Union.
The status means that the drug can be marketed in the union's 27 member countries, although additional data will need to be filed each year until full approval is granted, the company said today in a statement on Business Wire. (Bloomberg)